ELMCX
Price
$19.61
Change
+$0.17 (+0.87%)
Updated
Sep 16 closing price
Net Assets
6.84M
RNWAX
Price
$90.29
Change
+$0.57 (+0.64%)
Updated
Sep 16 closing price
Net Assets
74.08B
Interact to see
Advertisement

ELMCX vs RNWAX

Header iconELMCX vs RNWAX Comparison
Open Charts ELMCX vs RNWAXBanner chart's image
Lord Abbett Emerging Markets Equity C
Price$19.61
Change+$0.17 (+0.87%)
VolumeN/A
Net Assets6.84M
American Funds New World R1
Price$90.29
Change+$0.57 (+0.64%)
VolumeN/A
Net Assets74.08B
ELMCX vs RNWAX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 74.1B vs. ELMCX (6.84M). ELMCX pays higher dividends than RNWAX: ELMCX (0.34) vs RNWAX (0.00). ELMCX was incepted earlier than RNWAX: ELMCX (4 years) vs RNWAX (23 years). ELMCX (6.77) is less costly to investors than RNWAX (1.66). ELMCX is a more actively managed with annual turnover of: 79.00 vs. RNWAX (37.00). RNWAX has a lower initial minimum investment than ELMCX: RNWAX (250) vs ELMCX (1500). ELMCX annual gain was more profitable for investors over the last year : 24.87 vs. RNWAX (16.13).
ELMCXRNWAXELMCX / RNWAX
Total Expense Ratio1.901.66114%
Annual Report Gross Expense Ratio6.771.66408%
Fund Existence4 years23 years-
Gain YTD25.82522.627114%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets6.84M74.1B0%
Annual Yield % from dividends0.340.00-
Returns for 1 year24.8716.13154%
Returns for 3 years52.6346.78113%
Returns for 5 yearsN/A25.94-
Returns for 10 yearsN/A89.51-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STVN27.231.00
+3.81%
Stevanato Group SpA
DNTH37.470.43
+1.16%
Dianthus Therapeutics
SIMA10.46N/A
N/A
SIM Acquisition Corp I
FERAU10.50N/A
N/A
Fifth Era Acquisition Corp I
CPIX3.36-0.02
-0.59%
Cumberland Pharmaceuticals